Work

Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics

Year: 1998

Type: article

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/ajrccm.157.4.9707089

Authors: BARBRO DAHLÉN, EWA NIZANKOWSKA, ANDREW SZCZEKLIK, OLLE ZETTERSTRÖM, GRAZYNA BOCHENEK, MARIA KUMLIN, LUCYNA MASTALERZ, GRAZYNA PINIS, LINDA J. SWANSON, TERRY I. BOODHOO, STEPHEN WRIGHT, LOUISE M. DUBÉ, SVEN-ERIK DAHLÉN

Institutions: Jagiellonian University, Karolinska University Hospital, Karolinska Institutet

Language: English

Topic: Asthma and respiratory diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2136073528

FWCI: 21.93

Cites: 35

Cited by: 394

Related to: 10